Autopsy report · NCT02433158
Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease
Cause of deathFunding or business
“The B5201003 OLE study was terminated based on the failure of the 'parent" B5201002 study to meet its efficacy endpoints. Termination was not due to safety.”
Life of this trial
- Registered 8 months before it started.
- Ran for about 3 years 11 months before it stopped.
- 154 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- GlycoMimetics Incorporated
- Sponsor type
- Industry
- Conditions
- Sickle Cell Anemia; Sickle Cell Disease; Sickle Cell Disorders; Pain Crisis; Vaso-occlusive Crisis
- Interventions
- Rivipansel
- Participants
- 154
- Sites
- 97
- Countries
- Canada, United States
Trials that died the same way
- Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
“B7911002 was prematurely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014” - An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
“The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study” - A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
“This study was terminated due to limited efficacy and not due to safety reasons” - A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
“The study terminated for safety reasons” - Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
“This study was terminated for reasons not related to efficacy or safety”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.